市場調査レポート
商品コード
1424127

遺伝子検査サービスの市場規模および予測、世界および地域シェア、動向、成長機会分析レポート対象範囲:サービスタイプ別、疾患別、サービスプロバイダー別、地域別

Genetic Testing Services Market Size and Forecast, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type, Disease, Service Provider, and Geography

出版日: | 発行: The Insight Partners | ページ情報: 英文 193 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
遺伝子検査サービスの市場規模および予測、世界および地域シェア、動向、成長機会分析レポート対象範囲:サービスタイプ別、疾患別、サービスプロバイダー別、地域別
出版日: 2023年12月28日
発行: The Insight Partners
ページ情報: 英文 193 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

遺伝子検査サービス市場規模は、2022年の34億2,500万米ドルから2030年には105億5,600万米ドルに成長すると予想され、2022~2030年のCAGRは15.1%を記録すると推定されます。

遺伝子検査サービス市場の成長は、遺伝性疾患の有病率の増加、個別化医療に対する認識と受容の高まり、消費者直接遺伝子検査への嗜好の高まりに起因しています。しかし、遺伝子検査の社会的・倫理的な意味合いや遺伝子検査サービスの手ごろさが市場成長の妨げとなっています。

中国、インド、メキシコ、ブラジルなどの新興国は、市場関係者に大きな成長機会を提供しています。高い成長は、公的ヘルスケア支出の増加、ヘルスケアインフラの改善、対象患者数の多さに起因しています。また、新興経済諸国における遺伝性疾患とその早期診断に対する意識の高まりにより、遺伝子検査のニーズも高まっています。

遺伝学的サービスの質と利用可能性は、高所得国と中低所得国とで異なる場合があります。例えば、米国、オーストラリア、カナダ、英国、その他の欧州諸国では、遺伝サービスは十分に進歩し、確立され、広範囲に及んでいます。これらのサービスには、新生児スクリーニング、保因者同定スクリーニング、出生前診断が含まれます。しかし、多くの高所得国では、複数の環境で提供される遺伝学的サービスには、まだ改善された評価システムが必要です。

遺伝学的検査手順の容易さと適用可能性は、アジア太平洋およびその他の発展途上地域における研究開発活動に恩恵をもたらしています。主要市場プレーヤーは、これらの国々における製品の入手可能性、アクセシビリティ、流通網を改善するために、協定、共同研究、パートナーシップ、事業拡大などの戦略やイニシアティブに注力しています。これにより、早期診断と治療のニーズの高まりに対応することができます。例えば、2019年、ブラジルの大手遺伝子検査機関の1つであるGENOMIKAは、全ゲノムシークエンシングと予防医学および臨床遺伝学におけるこれらの検査に関連するすべてのサービスを自社のポートフォリオに組み込むことでベリタスと合意に達しました。

中国政府は、経済・社会発展のための第14次5カ年計画(2016~2020年)において、ゲノミクスを重要な戦略分野として位置づけています。2016年、中国科学院は、2030年までに1億人以上のヒトゲノムの塩基配列を決定する92億米ドルの14年プロジェクト「精密医療イニシアティブ」を開始しました。2017年12月、中国科学技術省はヒトゲノム研究プロジェクトに協力し、10万人の遺伝子構成を記録しました。9つの異なる少数民族の遺伝子データを用いて、研究者は遺伝子内の遺伝情報を解読することを望んでいます。さらに、新興経済諸国におけるDTC遺伝子検査に対する消費者の意識の高まりは、DTC業界に成長機会をもたらしています。

したがって、新興国の市場は、市場で活動するプレーヤーに大きな成長機会を提供し、予測期間中の市場成長を後押しすると予測されます。

2018年現在、市場で入手可能な遺伝子検査は~75,000件であり、毎日10件近くの新しい検査が市場に参入しています。2023年に発表された研究「米国における遺伝子検査の利用動向、2012年~2022年」によると、2022年11月現在、米国では~129,624件、世界全体では~197,779件の遺伝子検査が利用可能になり、遺伝子検査レジストリに提出されています。これらの検査は、単一遺伝子の検査から複数の遺伝子を調べるパネル検査へと広がっています。健康データの枯渇という増大する問題を解決するため、医療の分野では人工知能(AI)や機械学習といった臨床ツールの強化がますます中心となっており、ゲノム医療の受容性を向上させる方法として言及されています。今日、放射線科や循環器科などの分野で、臨床データを正しく分析・理解するために必要な膨大なデータを処理するために、多くの企業が機械学習に目を向けています。

市場に出回っている消費者向けの遺伝子検査技術の多くは、機械学習やAIを利用して機能しています。多くの点で、病気の遺伝子検査は、これらのプログラムが扱う必要のある膨大な量のデータのため、機械学習に最適な分野です。例えば、ヒトゲノムの解析には何十億ビットもの情報を読み取る必要があり、機械学習がイントロダクション導入される以前は、こうした作業の多くはかなり厄介なものだった。AIは遺伝子データを分析し、臨床専門家の診断をサポートする上で大きな可能性を提供します。

グーグルには、ヒトゲノムを徹底的にプロットするために使用できるディープ・バリアントと呼ばれるプログラムがあり、人の遺伝情報の全範囲に使用することができます。さらに、国立衛生研究所などの機関は、機械学習とAIが遺伝学とゲノミクスのより良い理解を深める方法に取り組んでいます。したがって、これらのツールをうまく統合することで、臨床医は希少な遺伝病をより効率的かつ効果的に診断できるようになると思われます。

サービスプロバイダーに基づく洞察

サービスプロバイダーに基づいて、遺伝子検査サービス市場は一般検査サービスとリキッドバイオプシーベースのCGP、MRD、MCEDサービスに区分されます。2022年には、一般検査サービス分野が市場の最大シェアを占め、2022-2023年に最も高いCAGRを記録すると予測されています。遺伝学的および分子学的検査は、多くの遺伝性疾患、遺伝的関連を有する体性または後天性疾患、および薬理遺伝学的反応を検出するための基本です。遺伝子、染色体、タンパク質の変化を分析するために、複数の遺伝子検査が利用可能です。適切な検査を選択する際、ヘルスケアプロバイダーは、疑われる疾患やそれらに典型的に関連する遺伝的変異を含むいくつかの要因を考慮します。市場で入手可能な数種類の遺伝子検査は、分子、染色体、生化学的メカニズム、遺伝子発現などに基づいています。

一般的な遺伝子検査は、毛髪、皮膚、血液、羊水(妊娠中の胎児を取り囲む液体)、その他の組織サンプルを用いて行われます。COVID-19 PCR検査は、ウイルスの遺伝物質セグメントに一致するプライマーを使用し、サンプルから抽出した遺伝物質の増幅を可能にし、ウイルスの存在を検出します。

米国疾病予防管理センター(Centers for Disease Control and Prevention)、米国食品医薬品局(US Food and Drug Administration)、世界保健機関(WHO)は、遺伝子検査サービス市場レポート作成時に参照した一次情報および二次情報のひとつです。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 遺伝子検査サービス市場情勢

  • PEST分析
    • 世界のPEST分析

第5章 遺伝子検査サービス市場-主要産業力学

  • 主要市場促進要因
    • 遺伝性疾患の有病率の上昇
    • 個別化医療に対する認識と受容の高まり
    • 消費者直接検査(DTC)に対する嗜好の高まり
  • 市場抑制要因
    • 遺伝子検査の社会的・倫理的意味合い
    • 遺伝学的サービスの手頃な価格
  • 市場機会
    • 新興国における未開拓の新興市場
  • 今後の動向
    • 人工知能による遺伝子検査
  • インパクト分析

第6章 遺伝子検査サービス市場:世界市場分析

  • 遺伝子検査サービス市場収益、2022年~2030年

第7章 遺伝子検査サービス市場-2030年までの収益と予測:サービスタイプ別

  • 遺伝子検査サービス市場収益シェア:サービスタイプ別、2022年・2030年(%)
  • 予測検査
  • キャリア検査
  • 出生前検査
  • 新生児スクリーニング
  • 診断用遺伝子検査
  • その他

第8章 遺伝子検査サービスの世界市場:2030年までの収益と予測:疾患別

  • 遺伝子検査サービス市場:2022年および2030年の疾患別売上高シェア(%)
  • がん
  • 心血管疾患
  • 代謝性疾患
  • その他の疾患

第9章 遺伝子検査サービスの世界市場:2030年までの収益と予測:サービスプロバイダー別

  • 遺伝子検査サービス市場収益シェア(サービスプロバイダー別)、2022年・2030年(%)
  • 一般検査サービス
  • リキッドバイオプシーに基づくCGP、MRD、MCEDサービス

第10章 遺伝子検査サービス市場:地域別分析

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • 中東・アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • 南アフリカ
    • その他中東とアフリカ
  • 中南米
    • ブラジル
    • アルゼンチン
    • その他中南米

第11章 遺伝子検査サービス市場-業界情勢

  • 遺伝子検査サービス市場における成長戦略
  • 有機的成長戦略
  • 無機的成長戦略

第12章 企業プロファイル

  • Eurofins Scientific SE
  • Exact Sciences Corp
  • Laboratory Corp of America Holdings
  • andMe Holding Co
  • Ambry Genetics Corp
  • Quest Diagnostics Inc
  • Illumina Inc
  • F. Hoffmann-La Roche Ltd
  • NeoGenomics Inc
  • Centogene AG
  • Bio-Rad Laboratories Inc

第13章 付録

図表

List Of Tables

  • Table 1. Genetic Testing Services Market Segmentation
  • Table 2. North America Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. North America Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. North America Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. North America General Testing Service Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. North America Liquid Biopsy-Based CGP, MRD, and MCED Service, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. US Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. US Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. US Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. Canada Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Canada Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. Canada Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. Mexico Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. Mexico Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. Mexico Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. Europe Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. Europe Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. Europe Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 19. Europe General Testing Service Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 20. Europe Liquid Biopsy-Based CGP, MRD, and MCED Service, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 21. UK Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 22. UK Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 23. UK Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 24. Germany Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 25. Germany Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 26. Germany Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 27. France Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 28. France Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 29. France Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 30. Italy Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 31. Italy Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 32. Italy Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 33. Spain Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 34. Spain Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 35. Spain Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 36. Rest of Europe Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 37. Rest of Europe Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 38. Rest of Europe Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 39. Asia Pacific Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 40. Asia Pacific Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 41. Asia Pacific Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 42. Asia Pacific Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 43. Asia Pacific Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 44. China Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 45. China Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 46. China Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 47. Japan Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 48. Japan Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 49. Japan Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 50. India Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 51. India Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 52. India Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 53. Australia Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 54. Australia Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 55. Australia Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 56. South Korea Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 57. South Korea Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 58. South Korea Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 59. Rest of Asia Pacific Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 60. Rest of Asia Pacific Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 61. Rest of Asia Pacific Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 62. Middle East & Africa Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 63. Middle East & Africa Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 64. Middle East & Africa Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 65. Middle East & Africa Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 66. Middle East & Africa Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 67. Saudi Arabia Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 68. Saudi Arabia Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 69. Saudi Arabia Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 70. UAE Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 71. UAE Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 72. UAE Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 73. South Africa Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 74. South Africa Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 75. South Africa Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 76. Rest of Middle East & Africa Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 77. Rest of Middle East & Africa Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 78. Rest of Middle East & Africa Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 79. South & Central America Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 80. South & Central America Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 81. South & Central America Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 82. South & Central America Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 83. South & Central America Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 84. Brazil Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 85. Brazil Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 86. Brazil Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 87. Argentina Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 88. Argentina Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 89. Argentina Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 90. Rest of South & Central America Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 91. Rest of South & Central America Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 92. Rest of South & Central America Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 93. Recent Organic Growth Strategies in Genetic Testing Services Market
  • Table 94. Recent Inorganic Growth Strategies in the Genetic Testing Services Market
  • Table 95. Glossary of Terms, Genetic Testing Services Market

List Of Figures

  • Figure 1. Genetic Testing Services Market Segmentation, By Geography
  • Figure 2. Global - PEST Analysis
  • Figure 3. Genetic Testing Services Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. Genetic Testing Services Market Revenue (US$ Mn), 2022 - 2030
  • Figure 6. Genetic Testing Services Market Revenue, Geography (US$ Mn), 2022 - 2030
  • Figure 7. Genetic Testing Services Market Revenue Share, by Service Type, 2022 & 2030 (%)
  • Figure 8. Predictive Testing: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Carrier Testing: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Prenatal Testing: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Newborn Screening: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Diagnostic Genetic Testing: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Others: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Genetic Testing Services Market Revenue Share, by Disease, 2022 & 2030 (%)
  • Figure 15. Cancer: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Cardiovascular Diseases: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Metabolic Diseases: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Other Diseases: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Genetic Testing Services Market Revenue Share, by Service Provider, 2022 & 2030 (%)
  • Figure 20. General Testing Service: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. General Testing Service: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Diagnostic Laboratories: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Others: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Liquid biopsy-based CGP, MRD, and MCED Service: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Hospital-Based Laboratories: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. Diagnostic Laboratories: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Others: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. North America: Genetic Testing Services Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 29. North America Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 30. North America Genetic Testing Services Market, By Key Countries, 2022 and 2030 (%)
  • Figure 31. US Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 32. Canada Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 33. Mexico Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 34. Europe Genetic Testing Services Market, by Key Country - Revenue, 2022 (US$ Million)
  • Figure 35. Europe Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 36. Europe Genetic Testing Services Market, By Key Countries, 2022 and 2030 (%)
  • Figure 37. UK Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 38. Germany Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 39. France Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 40. Italy Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 41. Spain Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 42. Rest of Europe Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 43. Asia Pacific Genetic Testing Services Market, by Key Country - Revenue, 2022 (US$ Million)
  • Figure 44. Asia Pacific Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 45. Asia Pacific Genetic Testing Services Market, By Key Countries, 2022 and 2030 (%)
  • Figure 46. China Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 47. Japan Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 48. India Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 49. Australia Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 50. South Korea Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 51. Rest of Asia Pacific Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 52. Middle East & Africa Genetic Testing Services Market, by Key Country - Revenue, 2022 (US$ Million)
  • Figure 53. Middle East & Africa Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 54. Middle East & Africa Genetic Testing Services Market, By Key Countries, 2022 and 2030 (%)
  • Figure 55. Saudi Arabia Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 56. UAE Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 57. South Africa Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 58. Rest of Middle East & Africa Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 59. South & Central America Genetic Testing Services Market, by Key Country - Revenue, 2022 (US$ Million)
  • Figure 60. South & Central America Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 61. South & Central America Genetic Testing Services Market, By Key Countries, 2022 and 2030 (%)
  • Figure 62. Brazil Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 63. Argentina Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 64. Rest of South & Central America Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 65. Growth Strategies in Genetic Testing Services Market
目次
Product Code: TIPHE100001383

The genetic testing services market size is expected to grow from US$ 3.425 billion in 2022 to US$ 10.556 billion by 2030; it is estimated to record a CAGR of 15.1% during 2022-2030.

The growth of the genetic testing services market is attributed to the growing prevalence of genetic diseases, increasing awareness and acceptance of personalized medicines, and growing preference for direct-to-consumer genetic testing. However, the social and ethical implications of genetic testing and the affordability of genetic services hinder market growth.

Emerging countries such as China, India, Mexico, and Brazil offer significant growth opportunities to market players. The high growth can be attributed to the increasing public healthcare expenditure, improving healthcare infrastructure, and a large target patient population. The need for genetic testing has also increased owing to a rise in awareness of genetic disorders and their early diagnosis in developing economies.

The quality and availability of genetic services may differ between high-income and low- to middle-income countries. For instance, genetic services are well-advanced, established, and extensive in the US, Australia, Canada, the UK, and other European countries. These services include newborn screening, carrier identification screening, and prenatal diagnosis. Yet, in many high-income countries, genetic services offered in multiple settings still need improved assessment systems.

The ease and applicability of genetic testing procedures have benefitted R&D activities in Asia Pacific and other developing regions worldwide. Major market players focus on strategies and initiatives, such as agreements, collaborations, partnerships, and expansions, to improve their product availability, accessibility, and distribution networks in these countries. This will help them address the growing need for early diagnosis and treatment. For instance, in 2019, GENOMIKA, one of Brazil's leading genetic testing laboratories, reached an agreement with Veritas to incorporate Whole Genome Sequencing and all the services associated with these tests in preventive medicine and clinical genetics into its portfolio.

The Chinese government identifies genomics as an important strategic field in its 14th Five-Year Plan (2016-2020) for economic and social development. In 2016, the Chinese Academy of Sciences launched the Precision Medicine Initiative, a 14-year project worth US$ 9.2 billion to sequence more than 100 million human genomes by 2030. In December 2017, China's Ministry of Science and Technology collaborated with a human genome research project to document the genetic makeup of 100,000 people. Using the genetic data of nine different minority groups, researchers desire to decode hereditary information within genes. In addition, rising consumer awareness regarding DTC genetic tests in developing economies offers growth opportunities to the DTC industry.

Therefore, emerging markets in developing countries are anticipated to offer significant growth opportunities to the players operating in the market and boost the market growth during the forecast period.

As of 2018, there were ~75,000 genetic tests available in the market, with nearly 10 new tests entering the market every day. As per the study "Trends in Availability of Genetic Tests in the United States, 2012-2022," published in 2023, ~129,624 and 197,779 genetic tests in the US and globally, respectively, have been made accessible and submitted to the genetic testing registry as of November 2022. These tests have been extended from single-gene tests to panels that look at multiple genes. To solve the growing problem of health data exhaust, the field of medicine is increasingly revolving around enhanced clinical tools, such as artificial intelligence (AI) and machine learning, which have been mentioned as a way to improve the acceptance of genomic medicine. Today, many companies have turned to machine learning to process the vast amount of data needed to analyze and understand clinical data correctly in fields such as radiology and cardiology.

Many of the consumer-facing genetic testing technologies available in the market use machine learning or AI to function. In numerous ways, genetic testing of diseases is the perfect field for machine learning because of the vast volumes of data that these programs need to struggle with. For example, working on the human genome includes reading billions of bits of information, and many of these tasks were pretty tricky before the introduction of machine learning. AI offers great potential in analyzing genetic data and supporting clinical specialists in diagnosing.

Google has a program called Deep Variant that can now be used to plot the human genome thoroughly and can be used on the full range of a person's genetic information. Moreover, agencies such as the National Institutes of Health are working on ways machine learning and AI can add to a better understanding of genetics and genomics. Thus, by successfully integrating these tools, clinicians will be able to diagnose rare genetic diseases more efficiently and effectively.

Service Provider -Based Insights

Based on the service provider, the genetic testing services market is segmented into general testing services and liquid biopsy-based CGP, MRD, and MCED services. In 2022, the general testing services segment held the largest share of the market and is anticipated to register the highest CAGR during 2022-2023. Genetic and molecular testing is fundamental for detecting many inherited disorders, somatic or acquired diseases with genetic associations, and pharmacogenetic responses. Multiple genetic tests are available to analyze genetic, chromosomal, or protein modifications. When selecting the suitable test, a healthcare provider considers several factors, including suspected conditions and genetic variations typically associated with them. Several types of genetic tests available in the market are based on molecular, chromosomal, and biochemical mechanisms, as well as gene expressions, among others.

General genetic tests are performed on hair, skin, blood, amniotic fluid (the fluid surrounding a fetus during pregnancy), or other tissue samples. COVID-19 PCR tests use primers matching a virus's genetic material segment, allowing the amplification of the genetic material extracted from samples to detect the presence of the virus.

Centers for Disease Control and Prevention, the US Food and Drug Administration, and the World Health Organization are among the primary and secondary sources referred to while preparing the genetic testing services market report.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the genetic testing services market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global genetic testing services market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Genetic Testing Services Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 Global PEST Analysis

5. Genetic Testing Services Market - Key Industry Dynamics

  • 5.1 Key Market Drivers
    • 5.1.1 Rising Prevalence of Genetic Diseases
    • 5.1.2 Increasing Awareness and Acceptance of Personalized Medicines
    • 5.1.3 Growing Preference for Direct-To-Consumer (DTC) Genetic Testing
  • 5.2 Market Restraints
    • 5.2.1 Social and Ethical Implications of Genetic Testing
    • 5.2.2 Affordability of Genetic Services
  • 5.3 Market Opportunities
    • 5.3.1 Untapped Emerging Markets in Developing Countries
  • 5.4 Future Trends
    • 5.4.1 Artificial Intelligence-Powered Genetic Testing
  • 5.5 Impact Analysis:

6. Genetic Testing Services Market - Global Market Analysis

  • 6.1 Genetic Testing Services Market Revenue (US$ Mn), 2022 - 2030

7. Global Genetic Testing Services Market - Revenue and Forecast to 2030 - by Service Type

  • 7.1 Overview
  • 7.2 Genetic Testing Services Market Revenue Share, by Service Type, 2022 & 2030 (%)
  • 7.3 Predictive Testing
    • 7.3.1 Overview
    • 7.3.2 Predictive Testing: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Carrier Testing
    • 7.4.1 Overview
    • 7.4.2 Carrier Testing: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Prenatal Testing
    • 7.5.1 Overview
    • 7.5.2 Prenatal Testing: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Newborn Screening
    • 7.6.1 Overview
    • 7.6.2 Newborn Screening: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Diagnostic Genetic Testing
    • 7.7.1 Overview
    • 7.7.2 Diagnostic Genetic Testing: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.8 Others
    • 7.8.1 Overview
    • 7.8.2 Others: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

8. Global Genetic Testing Services Market - Revenue and Forecast to 2030 - by Disease

  • 8.1 Overview
  • 8.2 Genetic Testing Services Market Revenue Share, by Disease, 2022 & 2030 (%)
  • 8.3 Cancer
    • 8.3.1 Overview
    • 8.3.2 Cancer: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Cardiovascular Diseases
    • 8.4.1 Overview
    • 8.4.2 Cardiovascular Diseases: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Metabolic Diseases
    • 8.5.1 Overview
    • 8.5.2 Metabolic Diseases: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Other Diseases
    • 8.6.1 Overview
    • 8.6.2 Other Diseases: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

9. Global Genetic Testing Services Market - Revenue and Forecast to 2030 - by Service Provider

  • 9.1 Overview
  • 9.2 Genetic Testing Services Market Revenue Share, by Service Provider, 2022 & 2030 (%)
  • 9.3 General Testing Service
    • 9.3.1 Overview
    • 9.3.2 General Testing Service: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.3.2.1 Hospital-Based Laboratories: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.3.2.2 Diagnostic Laboratories: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.3.2.3 Others: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Liquid biopsy-based CGP, MRD, and MCED Service
    • 9.4.1 Overview
    • 9.4.2 Liquid biopsy-based CGP, MRD, and MCED Service: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.4.2.1 Hospital-Based Laboratories: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.4.2.2 Diagnostic Laboratories: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.4.2.3 Others: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

10. Genetic Testing Services Market - Geographical Analysis

  • 10.1 North America Genetic Testing Services Market, Revenue and Forecast To 2030
    • 10.1.1 Overview
    • 10.1.2 North America Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
    • 10.1.3 North America: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
    • 10.1.4 North America: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
    • 10.1.5 North America: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 10.1.5.1 North America: General Testing Service, by Service Provider, 2020-2030 (US$ Million)
      • 10.1.5.2 North America: Liquid Biopsy-Based CGP, MRD, and MCED Service, by Service Provider, 2020-2030 (US$ Million)
    • 10.1.6 North America Genetic Testing Services Market, by Country
      • 10.1.6.1 US
        • 10.1.6.1.1 Overview
        • 10.1.6.1.2 US Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.6.1.3 US: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 10.1.6.1.4 US: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 10.1.6.1.5 US: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 10.1.6.2 Canada
        • 10.1.6.2.1 Overview
        • 10.1.6.2.2 Canada Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.6.2.3 Canada: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 10.1.6.2.4 Canada: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 10.1.6.2.5 Canada: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 10.1.6.3 Mexico
        • 10.1.6.3.1 Overview
        • 10.1.6.3.2 Mexico Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.6.3.3 Mexico: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 10.1.6.3.4 Mexico: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 10.1.6.3.5 Mexico: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
  • 10.2 Europe Genetic Testing Services Market, Revenue and Forecast to 2030
    • 10.2.1 Overview
    • 10.2.2 Europe Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
    • 10.2.3 Europe: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
    • 10.2.4 Europe: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
    • 10.2.5 Europe: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 10.2.5.1 Europe: General Testing Service, by Service Provider, 2020-2030 (US$ Million)
      • 10.2.5.2 Europe: Liquid Biopsy-Based CGP, MRD, and MCED Service, by Service Provider, 2020-2030 (US$ Million)
    • 10.2.6 Europe Genetic Testing Services Market, by Country
      • 10.2.6.1 UK
        • 10.2.6.1.1 Overview
        • 10.2.6.1.2 UK Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.6.1.3 UK: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 10.2.6.1.4 UK: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 10.2.6.1.5 UK: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 10.2.6.2 Germany
        • 10.2.6.2.1 Overview
        • 10.2.6.2.2 Germany Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.6.2.3 Germany: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 10.2.6.2.4 Germany: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 10.2.6.2.5 Germany: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 10.2.6.3 France
        • 10.2.6.3.1 Overview
        • 10.2.6.3.2 France Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.6.3.3 France: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 10.2.6.3.4 France: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 10.2.6.3.5 France: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 10.2.6.4 Italy
        • 10.2.6.4.1 Overview
        • 10.2.6.4.2 Italy Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.6.4.3 Italy: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 10.2.6.4.4 Italy: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 10.2.6.4.5 Italy: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 10.2.6.5 Spain
        • 10.2.6.5.1 Overview
        • 10.2.6.5.2 Spain Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.6.5.3 Spain: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 10.2.6.5.4 Spain: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 10.2.6.5.5 Spain: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 10.2.6.6 Rest of Europe
        • 10.2.6.6.1 Overview
        • 10.2.6.6.2 Rest of Europe Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.6.6.3 Rest of Europe: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 10.2.6.6.4 Rest of Europe: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 10.2.6.6.5 Rest of Europe: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
  • 10.3 Asia Pacific Genetic Testing Services Market, Revenue and Forecast to 2030
    • 10.3.1 Overview
    • 10.3.2 Asia Pacific Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
    • 10.3.3 Asia Pacific: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
    • 10.3.4 Asia Pacific: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
    • 10.3.5 Asia Pacific: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 10.3.5.1 Asia Pacific: General Testing Service, by Service Provider, 2020-2030 (US$ Million)
      • 10.3.5.2 Asia Pacific: Liquid Biopsy-Based CGP, MRD, and MCED Service, by Service Provider, 2020-2030 (US$ Million)
    • 10.3.6 Asia Pacific Genetic Testing Services Market, by Country
      • 10.3.6.1 China
        • 10.3.6.1.1 Overview
        • 10.3.6.1.2 China Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.6.1.3 China: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 10.3.6.1.4 China: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 10.3.6.1.5 China: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 10.3.6.2 Japan
        • 10.3.6.2.1 Overview
        • 10.3.6.2.2 Japan Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.6.2.3 Japan: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 10.3.6.2.4 Japan: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 10.3.6.2.5 Japan: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 10.3.6.3 India
        • 10.3.6.3.1 Overview
        • 10.3.6.3.2 India Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.6.3.3 India: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 10.3.6.3.4 India: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 10.3.6.3.5 India: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 10.3.6.4 Australia
        • 10.3.6.4.1 Overview
        • 10.3.6.4.2 Australia Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.6.4.3 Australia: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 10.3.6.4.4 Australia: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 10.3.6.4.5 Australia: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 10.3.6.5 South Korea
        • 10.3.6.5.1 Overview
        • 10.3.6.5.2 South Korea Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.6.5.3 South Korea: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 10.3.6.5.4 South Korea: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 10.3.6.5.5 South Korea: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 10.3.6.6 Rest of Asia Pacific
        • 10.3.6.6.1 Overview
        • 10.3.6.6.2 Rest of Asia Pacific Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.6.6.3 Rest of Asia Pacific: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 10.3.6.6.4 Rest of Asia Pacific: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 10.3.6.6.5 Rest of Asia Pacific: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
  • 10.4 Middle East & Africa Genetic Testing Services Market, Revenue and Forecast to 2030
    • 10.4.1 Overview
    • 10.4.2 Middle East & Africa Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
    • 10.4.3 Middle East & Africa: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
    • 10.4.4 Middle East & Africa: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
    • 10.4.5 Middle East & Africa: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 10.4.5.1 Middle East & Africa: General Testing Service, by Service Provider, 2020-2030 (US$ Million)
      • 10.4.5.2 Middle East & Africa: Liquid Biopsy-Based CGP, MRD, and MCED Service, by Service Provider, 2020-2030 (US$ Million)
    • 10.4.6 Middle East & Africa Genetic Testing Services Market, by Country
      • 10.4.6.1 Saudi Arabia
        • 10.4.6.1.1 Overview
        • 10.4.6.1.2 Saudi Arabia Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.6.1.3 Saudi Arabia: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 10.4.6.1.4 Saudi Arabia: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 10.4.6.1.5 Saudi Arabia: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 10.4.6.2 UAE
        • 10.4.6.2.1 Overview
        • 10.4.6.2.2 UAE Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.6.2.3 UAE: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 10.4.6.2.4 UAE: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 10.4.6.2.5 UAE: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 10.4.6.3 South Africa
        • 10.4.6.3.1 Overview
        • 10.4.6.3.2 South Africa Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.6.3.3 South Africa: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 10.4.6.3.4 South Africa: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 10.4.6.3.5 South Africa: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 10.4.6.4 Rest of Middle East & Africa
        • 10.4.6.4.1 Overview
        • 10.4.6.4.2 Rest of Middle East & Africa Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.6.4.3 Rest of Middle East & Africa: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 10.4.6.4.4 Rest of Middle East & Africa: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 10.4.6.4.5 Rest of Middle East & Africa: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
  • 10.5 South & Central America Genetic Testing Services Market, Revenue and Forecast to 2030
    • 10.5.1 Overview
    • 10.5.2 South & Central America Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
    • 10.5.3 South & Central America: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
    • 10.5.4 South & Central America: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
    • 10.5.5 South & Central America: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 10.5.5.1 South & Central America: General Testing Service, by Service Provider, 2020-2030 (US$ Million)
      • 10.5.5.2 South & Central America: Liquid biopsy-based CGP, MRD, and MCED Services, by Service Provider, 2020-2030 (US$ Million)
    • 10.5.6 South & Central America Genetic Testing Services Market, by Country
      • 10.5.6.1 Brazil
        • 10.5.6.1.1 Overview
        • 10.5.6.1.2 Brazil Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.5.6.1.3 Brazil: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 10.5.6.1.4 Brazil: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 10.5.6.1.5 Brazil: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 10.5.6.2 Argentina
        • 10.5.6.2.1 Overview
        • 10.5.6.2.2 Argentina Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.5.6.2.3 Argentina: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 10.5.6.2.4 Argentina: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 10.5.6.2.5 Argentina: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 10.5.6.3 Rest of South & Central America
        • 10.5.6.3.1 Overview
        • 10.5.6.3.2 Rest of South & Central America Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.5.6.3.3 Rest of South & Central America: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 10.5.6.3.4 Rest of South & Central America: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 10.5.6.3.5 Rest of South & Central America: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)

11. Genetic Testing Services Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in Genetic Testing Services Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Eurofins Scientific SE
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Exact Sciences Corp
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Laboratory Corp of America Holdings
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4andMe Holding Co
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Ambry Genetics Corp
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Quest Diagnostics Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Illumina Inc
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 F. Hoffmann-La Roche Ltd
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 NeoGenomics Inc
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Centogene AG
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments
  • 12.11 Bio-Rad Laboratories Inc
    • 12.11.1 Key Facts
    • 12.11.2 Business Description
    • 12.11.3 Products and Services
    • 12.11.4 Financial Overview
    • 12.11.5 SWOT Analysis
    • 12.11.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms